Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROAD: AD-35 in Mild to Moderate Alzheimer's Disease
NCT03625401Phase 2Unknown
- Sponsor
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Start
- Oct 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AD-35 in Alzheimer's disease (AD), sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
AD-35
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03625401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03625401.